Earnings · China A-shares
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Class A (301246) earnings
Hubei Hongyuan Pharmaceutical Technology Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +16846.38% year on year, +842.38% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved +0.66% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +16846.38%
- Excl. one-offs YoY
- +842.38%
- Net profit QoQ
- +135.47%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +8.06% | — |
| 3 days | +0.66% | — |
| 7 days | +7.93% | — |
| 14 days | -2.11% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +2.20%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥184.24M | +16846.38% | +842.38% | +47.39% | 0.46 | 4.05% | +0.66% | — | — |
| 2026 interim report | 2026-08-28 | ¥156.24M | +2788.93% | +838.60% | +52.05% | 0.39 | 3.44% | -11.59% | -25.57% | -15.88% |
| 2026 Q1 report | 2026-04-29 | ¥144.35M | +1524.43% | +21415.54% | +62.31% | 0.36 | 3.19% | +28.45% | +8.33% | +7.39% |
| 2025 annual report | 2026-04-29 | ¥119.05M | +131.33% | +871.30% | +9.53% | 0.30 | 2.73% | +28.45% | +8.33% | +7.39% |
| 2025 Q3 report | 2025-10-23 | -¥1.10M | -103.04% | — | -0.39% | 0.00 | -0.03% | +0.71% | +5.72% | +6.58% |
| 2025 interim report | 2025-08-28 | -¥5.81M | -116.23% | — | -1.73% | -0.01 | -0.13% | -3.29% | +13.48% | +7.98% |
| 2025 Q1 report | 2025-04-25 | ¥8.89M | -71.52% | -96.26% | +1.73% | 0.02 | 0.21% | -1.74% | +12.61% | +9.37% |
| 2024 annual report | 2025-04-25 | ¥51.47M | -40.96% | -80.83% | -13.83% | 0.13 | 1.18% | -1.74% | +12.61% | +9.37% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.